Patents by Inventor Donald S. BACKOS

Donald S. BACKOS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STAT3 transcription factor inhibitors and methods of using the same
    Patent number: 11952353
    Abstract: Compounds that inhibit the activity of Signal transducer and activator of transcription 3 (STAT3), or pharmaceutically acceptable salts or prodrugs thereof, and methods of using these compounds to treat cancer and other diseases.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: April 9, 2024
    Assignee: The Regents of the University of Colorado
    Inventors: Philip Reigan, Donald S. Backos, Christopher J. Matheson, Steffanie L. Furtek, Craig T. Jordan, Maria L. Amaya
  • STAT3 TRANSCRIPTION FACTOR INHIBITORS AND METHODS OF USING THE SAME
    Publication number: 20220017476
    Abstract: Compounds that inhibit the activity of Signal transducer and activator of transcription 3 (STAT3), or pharmaceutically acceptable salts or prodrugs thereof, and methods of using these compounds to treat cancer and other diseases.
    Type: Application
    Filed: December 6, 2019
    Publication date: January 20, 2022
    Inventors: Philip REIGAN, Donald S. BACKOS, Christopher J. MATHESON, Steffanie L. FURTEK, Craig T. JORDAN, Maria L. AMAYA
  • WEE1 KINASE INHIBITORS AND METHODS OF TREATING CANCER USING THE SAME
    Publication number: 20200405723
    Abstract: A compound, or a pharmaceutically acceptable salts or prodrugs thereof, having the chemical structure: and methods of using these compounds to inhibit WEE1 kinase and treat cancer in a subject.
    Type: Application
    Filed: February 28, 2019
    Publication date: December 31, 2020
    Inventors: Philip REIGAN, Donald S. BACKOS, Christopher J. MATHESON, Kimberly A. CASALVIERI